1009 Results

People

  1. Motzer
    Motzer
  2. O'Reilly
    O'Reilly
  3. Kris
    Kris
  4. Aghajanian
    Aghajanian
  5. Hudis
    Hudis
  6. Bajorin
    Bajorin
  7. Kelsen
    Kelsen
  8. Ginsberg
    Ginsberg
  9. Krug
    Krug
  10. Scher
    Scher

Groups

  1. Department of Medicine (716)
  2. Solid Tumor Oncology Division (483)
  3. Hematologic Malignancies, Division of (277)
  4. Center for Hematologic Malignancies (224)
  5. Survivorship Research (151)
  6. Genitourinary Oncology Service (136)
  7. Epidemiology and Biostatistics (119)
  8. Radiology, Department of (111)
  9. Biostatistics Service (109)
  10. GSK Faculty (104)
  1. "anemia"
Formats
  1. Journal Article (926)
  2. Review (42)
  3. Research Letter (15)
  4. Conference Paper (12)
  5. Editorial (4)
  6. Guidelines (3)
  7. Miscellaneous (3)
  8. Correspondence (2)
  9. Book Section (1)
  10. Meeting Abstract (1)
Groups
  1. Department of Medicine (716)
  2. Solid Tumor Oncology Division (483)
  3. Hematologic Malignancies, Division of (277)
  4. Center for Hematologic Malignancies (224)
  5. Survivorship Research (151)
  6. Genitourinary Oncology Service (136)

More Groups

People
  1. Robert Motzer (55)
  2. Eileen O'Reilly (35)
  3. Mark Kris (32)
  4. Carol Aghajanian (31)
  5. Clifford Hudis (31)
  6. Dean Bajorin (29)

More People

Years
  1. 2025 (41)
  2. 2024 (99)
  3. 2023 (56)
  4. 2022 (45)
  5. 2021 (25)
  6. 2020 (62)

More Years

Publications
  1. Journal of Clinical Oncology (69)
  2. Cancer (50)
  3. Clinical Cancer Research (49)
  4. Lancet Oncology (47)
  5. Gynecologic Oncology (34)
  6. Blood (29)

More Publications

Publishers
  1. Elsevier Inc. (147)
  2. Springer (90)
  3. Elsevier Science, Inc. (83)
  4. American Society of Clinical Oncology (74)
  5. Wiley Blackwell (65)
  6. Nature Publishing Group (61)

More Publishers

Results (1009)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Diagnostic challenges and proposed classification of myeloid neoplasms with overlapping features of thrombocytosis, ring sideroblasts and concurrent del(5q) and SF3B1 mutations
    Research Letter

    Kumar, J.; Lewis, N. E.; Sherpa, S.; Londono, D.; Sun, X.; Gao, Q.; Arcila, M. E.; Roshal, M.; Zhang, Y.; Xiao, W.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts
    Journal Article

    Choi, I. Y.; Ling, J. P.; Zhang, J.; Helmenstine, E.; Walter, W.; Tsakiroglou, P.; Bergman, R. E.; Philippe, C.; Manley, J. L.; Rouault-Pierre, K.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Bruton’s tyrosine kinase (BTK) inhibitors for the treatment of primary central nervous system lymphoma (PCNSL): Current progress and latest advances
    Review

    Schaff, L.; Nayak, L.; Grommes, C.
    Leukemia and Lymphoma (2024)

    Fulltext@MSK | Save
  • The International Association for the Study of Lung Cancer pleural mesothelioma staging project: Expanded database to inform revisions in the ninth edition of the TNM classification of pleural mesothelioma
    Journal Article

    Wolf, A. S.; Eisele, M.; Giroux, D. J.; Gill, R.; Nowak, A. K.; Bille, A.; Rice, D.; Ripley, R. T.; Opitz, I.; Galateau-Salle, F.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Immature platelet count responses of pediatric patients with immune-mediated thrombotic thrombocytopenic purpura
    Research Letter

    Reeves, H. M.; Zhu, M. L.; Maitta, R. W.
    Thrombosis Research (2024)

    Fulltext@MSK | Save
  • Basket study of oral progesterone antagonist onapristone extended release in progesterone receptor-positive recurrent granulosa cell, low-grade serous ovarian cancer, or endometrioid endometrial cancer
    Journal Article

    Andres, S.; Finch, L.; Iasonos, A.; Zhou, Q.; Girshman, J.; Chhetri-Long, R.; Green, H.; Jang, D.; O'Cearbhaill, R.; Kyi, C.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: Final analysis of clinically relevant subgroups in GRIFFIN
    Journal Article

    Chari, A.; Kaufman, J. L.; Laubach, J.; Sborov, D. W.; Reeves, B.; Rodriguez, C.; Silbermann, R.; Costa, L. J.; Anderson, L. D.; Nathwani, N.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas
    Journal Article

    Bhansali, R. S.; Ellin, F.; Relander, T.; Cao, M.; Li, W.; Long, Q.; Ganesan, N.; Stuver, R.; Horwitz, S. M.; Wudhikarn, K.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-cell lymphoma
    Journal Article

    Ryu Tiger, Y. K.; Jain, S.; Barta, S. K.; Tolu, S.; Estrella, B.; Sawas, A.; Lue, J. K.; Francescone, M. M.; Pro, B.; Amengual, J. E.
    Leukemia and Lymphoma (2024)

    Fulltext@MSK | Save
  • Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study
    Journal Article

    Nooka, A. K.; Kaufman, J. L.; Rodriguez, C.; Jakubowiak, A.; Efebera, Y.; Reeves, B.; Wildes, T. M.; Holstein, S. A.; Anderson, L. D. Jr; Badros, A.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save